Back to Treatments

Treatment

Sofosbuvir/Velpatasvir

1
Conditions
1
Trials
10K
Participants
70%
Average Safety

Condition Evidence

Acute hepatitis C

1 trials · 10K participants

98% effectiveness · 70% safety
Sofosbuvir/Velpatasvir | DFDA